Comparative study of remidazolam combined with dezocine anesthesia and propofol combined with dezocine anesthesia in painless oocyte retrieval guided by B-ultrasound

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000036222

Enrollment

Unknown

Registered

2020-08-21

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sterility

Interventions

trial group:Rimazolom toluenesulfonate

control group:Propofol

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. 300 patients with painless oocyte retrieval; 2. ASA grade I ~ II; 3. Age 18-45 years old, weight 50-70kg, body mass index 19-24, total number of large follicles 10-15; 4. Patients are voluntary and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who take opioids, antidepressants and anticonvulsants for a long time; 2. Patients with other mental disorders; 3. Patients with severe cardiopulmonary or hepatorenal dysfunction; 4. Patients with language or hearing impairment who are unable to communicate; 5. Patients who need to compress ovarian follicles to develop clearly.

Design outcomes

Primary

Measure	Time frame
blood pressure;heart rate;Blood oxygen saturation;Sleep time;Recovery time;Injection pain;Follicle rate;Fertilization rate;Pregnancy rate;Pregnancy rate;Pregnancy rate;NRS;	—

Secondary

Measure	Time frame
Postoperative nausea and vomiting;Patient satisfaction;	—

Countries

China

Contacts

Public ContactZhu Zhiwei

Reproductive Hospital Affiliated to Shandong University

18668955383@163.com+86 18668955383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026